PRSS-56 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-PRSS56
In stock
- SKU
- REC-PRSS56
Target Overview
PRSS-56 (UniProt P0CW18; gene PRSS56) is a 603-amino-acid serine protease classified under EC 3.4.21.- and required during eye development. This recombinant form is produced in HEK293 mammalian cells, providing a eukaryotic expression environment that supports the post-translational processing and folding characteristic of the native human protein — attributes particularly relevant for serine proteases whose activity depends on correct zymogen maturation and disulfide architecture. The full-length sequence spans 603 residues. Because HEK293-derived material undergoes mammalian glycosylation and signal-peptide processing, this recombinant is well suited to enzymatic characterisation studies where conformational fidelity matters. Researchers routinely employ recombinant PRSS-56 in fluorogenic substrate cleavage assays to define substrate preference and kinetic parameters (Km, kcat), and in small-molecule inhibitor screens to determine IC50 values against serine protease inhibitor scaffolds. A second primary use is antibody validation. Recombinant PRSS-56 serves as a defined positive-control antigen in Western blot titration experiments and dot-blot assays, enabling researchers to confirm antibody specificity before committing to tissue or cell-lysate experiments. Researchers using this recombinant for antibody validation work can pair it directly with the matched Triple Point Biologics anti-PRSS56 antibody (SKU: RP-PRSS56), which has been validated for Western blot against human targets. The protein is also appropriate for surface plasmon resonance (SPR) or bio-layer interferometry (BLI) binding studies aimed at identifying protein-protein interaction partners relevant to its developmental signalling context, and for generating standard curves in quantitative ELISA formats where a sequence-verified, species-matched antigen is required.
Background
Applications
- Fluorogenic peptide substrate cleavage assay to determine Km and kcat for candidate serine protease substrates
- Small-molecule inhibitor IC50 determination using continuous fluorescence read-out formats
- Western blot positive-control antigen for anti-PRSS56 antibody validation (pairs with Triple Point Biologics RP-PRSS56)
- ELISA standard curve generation using sequence-verified recombinant antigen
- Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) binding studies to identify protein-protein interaction partners
- Variant functional benchmarking — comparison of wild-type vs. missense-variant PRSS-56 catalytic activity in parallel in-vitro assays
- Mass spectrometry-based substrate identification (degradomics) to map the PRSS-56 cleavage specificity profile
References
- Almhmoudi F et al. Posterior microphthalmia related to PRSS56 variants in a Saudi cohort: a longitudinal study of visual function. J AAPOS. 2026. doi:10.1016/j.jaapos.2026.104865. PMID: 42184889.
- Luo J et al. Whole-exome sequencing identifies PRSS56 variants in Chinese patients with microphthalmia. BMC Med Genomics. 2026. doi:10.1186/s12920-026-02376-9. PMID: 42015194.
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Secreted (most); pancreas + serum (digestive proteases) |
Frequently Asked Questions
What is the expected molecular weight of recombinant PRSS-56 on SDS-PAGE and Western blot?
The PRSS-56 open reading frame encodes 603 amino acids, giving a predicted unmodified MW of ~67 kDa. Because this recombinant is produced in HEK293 cells and undergoes mammalian N-linked glycosylation, the apparent MW on SDS-PAGE typically runs at 75–85 kDa — a shift consistent with glycoprotein behaviour. On Western blot under reducing conditions, expect a diffuse band in that 75–85 kDa window. Purity is confirmed >95% by SDS-PAGE prior to release. If you are using our matched antibody RP-PRSS56 for the blot, this band serves as your positive control reference.
Is recombinant PRSS-56 supplied as a zymogen or as the mature processed form?
PRSS-56 is a serine protease that undergoes zymogen maturation; the HEK293 expression system used here supports signal-peptide cleavage and the post-translational folding required for correct disulfide architecture. The recombinant supplied by Triple Point Biologics is the processed, active-enzyme form — not the uncleaved zymogen. This is relevant if you are running substrate-cleavage or inhibitor assays where pre-activation steps would otherwise introduce variability. The active form also means you can proceed directly to kinetic characterisation without an in vitro activation protocol.
What fluorogenic substrate should I use to measure PRSS-56 serine protease activity?
PRSS-56 is classified under EC 3.4.21.- (serine endopeptidases). For initial activity screening, synthetic fluorogenic substrates with a Arg-AMC or Lys-AMC scaffold (e.g., Boc-Phe-Ser-Arg-AMC or H-Arg-AMC) are a reasonable starting point given the trypsin-like cleavage preference common to this class. Monitor release of AMC fluorescence at Ex 380 nm / Em 460 nm. Because PRSS-56's precise substrate preference is still being characterised in the literature, we recommend running a substrate panel at 100–200 µM substrate concentration against 50–200 nM enzyme to identify highest-signal hits before committing to kinetic measurements.
What assay buffer conditions work best for PRSS-56 activity assays?
The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is compatible with direct use in activity assays at low dilution, provided glycerol carry-over does not exceed ~1% in the final reaction volume. For kinetic assays (Km, kcat determination), dilute enzyme into a working buffer of 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.01% Tween-20 to minimise surface adsorption at low enzyme concentrations. Avoid Ca²⁺ chelators (EGTA, EDTA) unless your experimental design requires them. Maintain pH between 7.0 and 8.0; serine protease activity typically drops sharply below pH 6.5.
What starting enzyme concentration should I use for an IC50 inhibitor screen against recombinant PRSS-56?
For a well-behaved IC50 determination, enzyme concentration in the assay well should be at or below the anticipated Ki of your inhibitor scaffold — typically 10–50 nM recombinant PRSS-56 is a practical starting range. Run an activity-versus-concentration curve first (1–500 nM) to identify a linear signal window. Substrate should be held below Km (empirically determined) to satisfy the Morrison tight-binding assumptions if you expect sub-nanomolar inhibitors. Pre-incubate enzyme with inhibitor for 30 min at room temperature before substrate addition to allow equilibrium binding. Stock concentration of REC-PRSS56 should be verified by A280 or BCA before the screen.
Can I use recombinant PRSS-56 (REC-PRSS56) as a positive control for Western blot with the matched antibody RP-PRSS56?
Yes — this is one of the primary use cases for REC-PRSS56 alongside RP-PRSS56. The rabbit polyclonal antibody RP-PRSS56 was validated against this recombinant in-house, so the two reagents are guaranteed compatible for Western blot positive-control applications. Load 50–100 ng of REC-PRSS56 per lane under reducing conditions; you should see a clean band at 75–85 kDa with RP-PRSS56 at its recommended primary antibody dilution. This also makes REC-PRSS56 a reliable standard for antibody lot-to-lot consistency checks and for validating antibody performance in new cell or tissue lysate backgrounds.
How much recombinant PRSS-56 should I load for a Western blot positive control lane?
50–100 ng per lane is sufficient for a strong, clean signal with RP-PRSS56 on standard PVDF or nitrocellulose membranes. If you are optimising antibody dilution simultaneously, running a titration of 10, 25, 50, and 100 ng across adjacent lanes gives a useful signal-linearity check. Resolve on a 10% or gradient (8–12%) SDS-PAGE gel to best resolve the 75–85 kDa glycosylated band. At >200 ng the band can appear diffuse due to glycan heterogeneity, which is normal for HEK293-expressed glycoproteins and does not indicate protein degradation.
How should I store and handle recombinant PRSS-56 to preserve enzymatic activity long-term?
REC-PRSS56 is shipped in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and arrives ready to use — no reconstitution required. Store at -20°C in the single-use aliquots provided; repeated freeze-thaw cycles progressively reduce activity and should be avoided. For working stocks used within a week, storage at 4°C is acceptable, but activity loss beyond 5–7 days at 4°C has been observed for serine proteases of this class. Add BSA (0.05–0.1 mg/mL) to diluted working solutions to reduce adsorptive losses at low enzyme concentrations (<10 nM). Do not heat above 37°C during assay setup.
Validation imagery coming soon
Western blot validation figures for REC-PRSS56 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.